G73.1 is the authoritative medical code for Lambert-Eaton syndrome in neoplastic disease. This classification is used in medical billing and clinical recording to specify the clinical criteria for lambert-eaton syndrome in neoplastic disease (ICD-10-CM G73.1), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Sequencing, inclusion, and exclusion notes published for G73.1 in the official ICD-10-CM tabular list.
Conditions that can never be reported with this code; the two are mutually exclusive.
Underlying conditions that must be sequenced before this code.
Per Excludes1 instructions, G73.1 must not be reported with: Lambert-Eaton syndrome not associated with neoplasm (G70.80-G70.81).
Yes. Code first: underlying neoplasm (C00-D49).
Official ICD-10-CM classifications in the same code family as G73.1, with their registry titles.
Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code.
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: